Adage Capital Management
Adage Capital is a Boston-based hedge fund founded by Phillip Gross which held nearly $24 billion in securities at the end of the quarter ended September 30, 2010.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
View Older Stories View More Recent Stories
-
Form SC 13G/A Ambrx Biopharma Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Authentic Equity Acquisi Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A DiamondHead Holdings Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Catcha Investment Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A PROKIDNEY CORP. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Decarbonization Plus Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Perception Capital Corp. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A MoonLake Immunotherapeut Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Kairos Acquisition Corp. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Jack Creek Investment Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Metals Acquisition Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Emerging Markets Horizon Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A FOXO TECHNOLOGIES INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ESGEN Acquisition Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A CinCor Pharma, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A 89bio, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Sitio Royalties Corp. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G BioXcel Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Rain Oncology Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form D/A Adage Capital Partners,
-
Form SC 13G Syros Pharmaceuticals, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13D/A East Resources Acquisiti Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Leap Therapeutics (LPTX) Acquires Flame Biosciences
-
Leap Therapeutics Acquires Flame Biosciences
-
Form SC 13G Independence Contract Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G ImmunoGen, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Wave Life Sciences Ltd. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Aura Biosciences, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Cabaletta Bio (CABA) Announces $35 Million Offering of Common Stock, Warrants
-
Cabaletta Bio Announces $35 Million Offering
-
Cabaletta Bio Announces $35 Million Offering
-
Form SC 13G Finance of America Compa Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Karyopharm Therapeutics (KPTI) Announces $165 Million Private Placement
-
Karyopharm Announces $165 Million Private Placement
-
Form SC 13G Stronghold Digital Minin Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Farallon, Franklin Templeton among potential winners in Twitter
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Sep 30
-
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
-
BioAtla (BCAB) Sells 9.745M Shares at $6.67
-
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
-
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
-
Rain Therapeutics (RAIN) Prices 6.86M Share Offering at $5.83/sh
-
Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
-
Abeona Therapeutics (ABEO) Prices 7.6M Share Private Placement at $4.6/sh
-
Abeona Therapeutics Announces $35 Million Private Placement Financing
-
Abeona Therapeutics Announces $35 Million Private Placement Financing
-
Compass Therapeutics (CMPX) Prices 25M Share Private Placement at $3.21/sh
-
Compass Therapeutics Announces $80 Million Private Placement
-
Form SC 13G Travere Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Investors who stuck it out for Musk's Twitter deal set to reap rewards

